Humana Inc. HUM SPX

Q: What is the current share price of Humana Inc. (HUM)?

As of 2026-07-14 21:23 PDT, Humana Inc. (HUM) trades at $406.77 on NYSE. Its 52-week range is $162.46 to $409.42.

Q: What is the market capitalisation of HUM?

Humana Inc. (HUM) has a market capitalisation of $48.84B on NYSE.

Q: What is the P/E ratio of HUM?

HUM trades at a trailing price-to-earnings (P/E) ratio of 43.41. The industry average P/E is 25.41. Its price-to-book (P/B) ratio is 2.45.

Q: Does HUM pay a dividend?

Humana Inc. (HUM) currently offers a dividend yield of 0.93%.

Q: What is the return on equity (ROE) of HUM?

HUM has a return on equity (ROE) of 6.28%. Its return on capital employed (ROCE) is 8.30%.

Q: Is HUM a good stock to buy?

This page provides a data-driven analysis of Humana Inc. (HUM), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Healthcare · Healthcare Plans · United States

https://www.humana.com

Company Profile ↓

$406.77

+81.41% 1Y

Mkt Cap$48.84B

P/E43.41

P/B2.45

Div. Yield0.93%

52W High$409.42

52W Low$162.46

Book Value$154.75

EPS (TTM)$9.37

Company Overview

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Why Investors Should Care

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

Dec 2025 Revenue of $129.66B (+10.1% YoY); net profit $1.19B.
Trailing 12 Months Year-on-year growth — revenue +23.5%, earnings -4.6%.
5-Year Trend Long-term compounding — revenue CAGR 9.5%, profit CAGR 2.0%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	9.51%
1 Year:	23.50%

Compounded Profit Growth

5 Years:	1.99%
1 Year:	-4.60%

Stock Price Performance

1 Year:	+81.41%
6 Months:	+48.02%
3 Months:	+105.69%
1 Month:	+10.59%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish

52-Week Range 99% of range

$162.46 $409.42

Trend Signals

Price vs 50-DMAAbove
Price vs 200-DMAAbove
RSI (14)71.63 · Overbought

Price Performance

1M+10.59%

3M+105.69%

6M+48.02%

1Y+81.41%

Valuation vs Sector

P/E of 43.41 is above the sector median of 25.41 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

Generates positive free cash flow.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

43.41

Industry PE

25.41

Forward P/E

25.85

PEG Ratio

2.15

Book Value

$154.75

Price to Book

2.45

P/S

0.33

EV/EBITDA

11.30

Dividend Yield

0.93%

Growth (CAGR)

Revenue 5Y

9.51%

Profit 5Y

1.99%

Revenue (YoY)

23.50%

Earnings (YoY)

-4.60%

Profitability & Returns

ROCE

8.30%

ROE

6.28%

ROA

3.64%

Profit Margin

0.82%

Op Margin

4.67%

Gross Margin

14.01%

EPS (Latest Qtr)

$9.83

EPS (TTM)

$9.37

Balance Sheet & Liquidity

Debt/Equity

0.77

Quick Ratio

1.26

Current Ratio

1.77

Debt

$14.37B

Total Assets

$55.28B

Current Assets

Working Capital

Ownership

Promoter Holding

0.21%

Chg in Prom Hold

FII / Inst Holding

99.87%

Chg in FII Hold

-0.03%

Financial Snapshot

Enterprise Value

$48.84B

Total Revenue (TTM)

$137.20B

EBITDA

$3.36B

Free Cash Flow

$1.43B

Operating Cash Flow

$1.84B

Shares Outstanding

120.06M

Gross Margin

14.01%

Payout Ratio

37.78%

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	HUM Humana Inc. SPX	406.77	43.41	$48.84B	0.93%	8.30%	6.28%	9.51%	1.99%
2	LLY Eli Lilly and Company SPX	1,152.54	41.02	$1.03T	0.61%	-	107.46%	7.20%	11.41%
3	JNJ Johnson & Johnson SPX	253.85	29.45	$611.07B	2.23%	14.88%	26.42%	2.43%	4.76%
4	ABBV AbbVie Inc. SPX	244.78	119.40	$432.48B	3.04%	10.47%	-129.24%	1.75%	-29.06%
5	UNH UnitedHealth Group Incorporated SPX	425.19	32.02	$386.13B	2.27%	9.74%	12.18%	10.40%	5.43%
6	MRK Merck & Co., Inc. SPX	120.78	34.02	$298.31B	2.86%	-	18.94%	5.64%	10.01%
7	AZN AstraZeneca PLC NDX	164.50	24.81	$255.12B	1.77%	15.97%	23.48%	9.82%	45.96%
8	TMO Thermo Fisher Scientific Inc. SPX	534.07	29.33	$198.47B	0.40%	8.14%	13.52%	8.81%	12.95%
9	AMGN Amgen Inc. NDXSPX	355.25	24.69	$191.73B	2.84%	18.02%	101.32%	11.77%	5.58%

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Dec 2014	Mar 2015	Jun 2015	Sep 2015	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026
Revenue	12.33B	13.83B	13.73B	13.36B	13.36B	13.80B	14.01B	13.69B	12.88B	13.76B	13.53B	13.28B	13.19B	14.28B	14.26B	14.21B	14.17B	16.11B	16.25B	16.24B	16.30B	18.93B	19.08B	20.07B	20.67B	20.64B	20.70B	23.97B	23.66B	22.80B	26.74B	26.75B	26.42B	29.61B	29.54B	29.40B	32.11B	32.39B	32.65B	39.65B
Operating Income	-	790.00M	573.00M	695.00M	-	547.00M	683.00M	949.00M	-	1.74B	1.10B	858.00M	-	760.00M	862.00M	961.00M	-	847.00M	1.11B	868.00M	-	1.07B	2.44B	1.82B	1.22B	1.24B	628.00M	1.29B	1.22B	1.17B	1.72B	1.44B	1.21B	1.24B	1.14B	728.00M	2.01B	1.10B	400.00M	1.75B
Net Income	145.00M	430.00M	431.00M	314.00M	101.00M	254.00M	311.00M	450.00M	-401.00M	1.11B	650.00M	499.00M	184.00M	491.00M	193.00M	644.00M	355.00M	566.00M	940.00M	689.00M	512.00M	473.00M	1.83B	1.34B	828.00M	588.00M	1.53B	930.00M	696.00M	1.20B	1.24B	959.00M	832.00M	741.00M	679.00M	480.00M	1.24B	545.00M	195.00M	1.19B
Diluted EPS	0.94	2.82	2.85	2.09	0.67	1.68	2.06	2.98	-2.68	7.49	4.46	3.44	1.29	3.53	1.39	4.65	2.58	4.16	6.94	5.14	3.84	3.56	13.75	10.05	6.39	4.55	11.84	7.29	5.48	9.39	9.87	7.66	6.71	6.11	5.62	3.98	10.30	4.51	1.62	9.83

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	25.29B	28.95B	30.74B	33.60B	36.83B	39.13B	41.31B	48.50B	54.29B	54.38B	53.77B	56.91B	64.89B	77.16B	83.06B	92.87B	106.37B	117.76B	129.66B
Operating Income	1.36B	1.07B	1.71B	1.85B	2.34B	2.02B	2.06B	2.36B	2.35B	1.74B	4.26B	3.10B	3.19B	4.99B	3.15B	3.80B	4.01B	2.56B	2.70B
Net Income	833.68M	647.15M	1.04B	1.10B	1.42B	1.22B	1.23B	1.15B	1.28B	614.00M	2.45B	1.68B	2.71B	3.37B	2.93B	2.81B	2.49B	1.21B	1.19B
Diluted EPS	4.91	3.83	6.15	6.47	8.46	7.47	7.73	7.36	8.44	4.07	16.81	12.16	20.10	25.31	22.67	22.08	20.00	9.98	9.84

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2006	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	13.04B	14.15B	16.10B	17.71B	19.98B	20.73B	23.53B	24.68B	25.40B	27.18B	25.41B	29.07B	34.97B	44.36B	43.05B	47.06B	46.48B	48.91B
Total Equity	3.05B	4.03B	4.46B	5.78B	6.92B	8.06B	8.85B	9.32B	9.65B	10.35B	10.69B	9.84B	10.16B	12.04B	13.73B	16.08B	15.31B	16.26B	16.38B	17.66B
Cash & Equivalents	1.74B	2.04B	1.97B	1.61B	1.67B	1.38B	1.31B	1.14B	1.94B	2.57B	3.88B	4.04B	2.34B	4.05B	4.67B	3.39B	5.06B	4.69B	2.22B	4.20B
Long Term Debt	-	-	1.94B	1.68B	1.67B	1.66B	2.61B	2.60B	3.83B	3.79B	3.79B	4.77B	4.38B	4.97B	6.06B	10.54B	9.03B	10.21B	11.14B	12.37B
Total Liabilities	-	-	8.58B	8.38B	9.18B	9.64B	11.13B	11.42B	13.88B	14.33B	14.71B	17.34B	15.25B	17.04B	21.24B	28.25B	27.68B	30.75B	30.03B	31.17B
Current Liabilities	-	-	5.18B	5.26B	5.74B	6.06B	6.38B	6.32B	7.47B	8.15B	7.82B	9.41B	10.08B	10.93B	13.39B	15.33B	17.18B	18.87B	16.94B	16.35B

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	1.22B	982.31M	1.42B	2.24B	2.08B	1.92B	1.72B	1.62B	868.00M	1.94B	4.05B	2.17B	5.28B	5.64B	2.26B	4.59B	3.98B	2.97B	921.00M
Investing Cash Flow	-1.85B	-498.32M	-1.86B	-1.81B	-1.36B	-1.97B	-1.18B	-63.00M	320.00M	-1.36B	-2.94B	-3.09B	-1.28B	-3.06B	-6.56B	-1.01B	-3.49B	-2.95B	2.27B
Financing Cash Flow	921.28M	-554.02M	80.00M	-371.00M	-1.02B	-29.00M	-702.00M	-758.00M	-552.00M	732.00M	-945.00M	-785.00M	-2.29B	-1.96B	3.02B	-1.91B	-856.00M	-2.49B	-1.22B
Capital Expenditure	-239.24M	-261.57M	-185.00M	-222.00M	-346.00M	-410.00M	-441.00M	-528.00M	-523.00M	-527.00M	-524.00M	-612.00M	-736.00M	-964.00M	-1.34B	-1.14B	-1.00B	-575.00M	-546.00M
Free Cash Flow	985.02M	720.74M	1.24B	2.02B	1.73B	1.51B	1.27B	1.09B	345.00M	1.41B	3.53B	1.56B	4.55B	4.67B	920.00M	3.45B	2.98B	2.39B	375.00M
Share Buybacks	27.41M	106.07M	23.00M	108.00M	541.00M	518.00M	531.00M	872.00M	385.00M	104.00M	3.37B	1.09B	1.07B	1.82B	79.00M	2.10B	1.57B	817.00M	151.00M
Dividends Paid	-	-	0	0	82.00M	165.00M	168.00M	172.00M	172.00M	177.00M	220.00M	265.00M	291.00M	323.00M	354.00M	392.00M	431.00M	431.00M	430.00M

Ratios (Annual)

Figures in %.

Metric	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Margin %	5.4%	3.7%	5.6%	5.5%	6.4%	5.2%	5.0%	4.9%	4.3%	3.2%	7.9%	5.4%	4.9%	6.5%	3.8%	4.1%	3.8%	2.2%	2.1%
Net Margin %	3.3%	2.2%	3.4%	3.3%	3.9%	3.1%	3.0%	2.4%	2.4%	1.1%	4.6%	3.0%	4.2%	4.4%	3.5%	3.0%	2.3%	1.0%	0.9%
ROE %	20.7%	14.5%	18.0%	15.9%	17.6%	13.8%	13.2%	11.9%	12.3%	5.7%	24.9%	16.6%	22.5%	24.5%	18.2%	18.3%	15.3%	7.4%	6.7%
ROCE %	-	13.7%	19.2%	17.9%	20.1%	14.8%	14.3%	14.7%	14.2%	9.9%	24.0%	20.2%	17.6%	23.1%	10.8%	14.7%	14.2%	8.7%	8.3%

Shareholding Pattern

Insiders

0.21%

Institutions

99.87%

Public Float

100.08%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Dodge & Cox Inc.	9.48%	11.38M	$4.46B
2	Blackrock Inc.	8.49%	10.20M	$3.99B
3	Vanguard Capital Management LLC	6.53%	7.84M	$3.07B
4	Vanguard Portfolio Management LLC	4.84%	5.81M	$2.27B
5	Pzena Investment Management LLC	4.56%	5.47M	$2.14B
6	State Street Corporation	4.54%	5.45M	$2.14B
7	Massachusetts Financial Services Co.	3.73%	4.48M	$1.76B
8	Sessa Capital IM, L.P.	3.10%	3.73M	$1.46B
9	Geode Capital Management, LLC	2.77%	3.33M	$1.30B
10	JPMORGAN CHASE & CO	2.53%	3.03M	$1.19B

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for HUM

Google News Mon, 13 Jul 2026

symbol__ Stock Quote Price and Forecast - CNN

<a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTFByOWp3STJseXY1cnJaNWtsN0JiRWlDM2tBTDJ1ekpkS2xGdDEyTXR1MzFKU2FOZ1RoTGJYbmNYUWhJZWtUeUo5RkJtQ01XRjA?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a>  <font…

Google News Wed, 08 Jul 2026

Humana (HUM) Stock Stays Near Fair Value As Earnings And Growth Pull Apart - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOMDB6aXBQMFJVNlRkRERtTVM1dmNOd0xqR190Z2paUS1oc2d5aUpLc2xWZS1USVl3UGE3QWVHYXUxU3RqMzhGaGVINnF0RmpkMjZacUVKMHFSS09veGVFSjJGQXZwRGFKdDJFRFE0UWZkUVM1S1JRbjlCdXVFUGFBU2ZuTjdDR1YxTUp0Rk…

Google News ue, 14 Jul 2026

HUM Maintained by TD Cowen -- Price Target Raised to $350 - GuruFocus

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQM19TdkNvMmtab2xzRE53WGxFNTh6eUgybHVDTThpN0w3QzBoXzhIcXViOUxiUXNSVHFxOGpkWGx1aG9kYkUyOWZJQkt2TEJUV2ZQSHhlR3Y4QVY0b2ZHbWw2dkJac1J2MjJWWEZoSFJwM0NGVjdua3hocUREMUJSWXpBTkU4ZGluZTNYNG…

Google News ue, 14 Jul 2026

Humana (NYSE:HUM) Price Target Raised to $415.00 - MarketBeat

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxOcUNnUGNNVklWWFJGOXRicTQ5b19JSUtSc3dXeFViYkhLMHlkXzVzWmVPOVE4MnV3Y3hhZzBDT2F5b3JVak5CM1Z5dE1JQVFMQXk0U1J3UHh4WVNWT3o4S2tDX092S295LTJvQVo2NHF3Y0NlOUZVc0hLbGI5VGVndVpBdElsWVNkeVBLRG…

Google News hu, 09 Jul 2026

Humana (HUM) Stock Looks Fully Priced On Illinois Medicaid Win - Sahm

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQZUF5SzRFSkJ0SzVDZFRfU2RiX1czY2xQamQ2QVQtMEZYZkZQbU02MmxiZ0RWUFg4TlNYcW5rQ2FjUnN1Q0dkVFZaLV9zTUdVbjRPRXZwWl9HNHJqcEk3ZEN0aEEzYmZFZVFDbHl0bkcyUU1hdFBwT3l6MEZua283NVJnMWFMMnZ0cmdHYm…

Google News Mon, 13 Jul 2026

Humana pops as Wells Fargo upgrades on moderating cost trends (HUM:NYSE) - Seeking Alpha

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQNDBDbXkyMW8wcThsSENjOENwU0VDcnoxZ3QzX2IyUTZDT1haMlNZY011U2E0ZGZDcDFOVTFod1Jtc1REVURMN0RQNVJIbEdzNmJaN1Y1aFNhbThwX2E5V253Uk1IUlpVWWoxNW5XS1N6VFlSQVV5TmcyMG9UajU4a1d5ZGt3SjUwV19pSW…

HUM — Frequently Asked Questions

What is the current share price of Humana Inc. (HUM)?

As of 2026-07-14 21:23 PDT, Humana Inc. (HUM) trades at $406.77 on NYSE. Its 52-week range is $162.46 to $409.42.

What is the market capitalisation of HUM?

Humana Inc. (HUM) has a market capitalisation of $48.84B on NYSE.

What is the P/E ratio of HUM?

HUM trades at a trailing price-to-earnings (P/E) ratio of 43.41. The industry average P/E is 25.41. Its price-to-book (P/B) ratio is 2.45.

Does HUM pay a dividend?

Humana Inc. (HUM) currently offers a dividend yield of 0.93%.

What is the return on equity (ROE) of HUM?

HUM has a return on equity (ROE) of 6.28%. Its return on capital employed (ROCE) is 8.30%.

Is HUM a good stock to buy?

This page provides a data-driven analysis of Humana Inc. (HUM), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

Humana Inc. HUM SPX

Company Overview

Why Investors Should Care

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Compounded Profit Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Peer comparison

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Top Institutional Holders

Analyst View

Latest News

symbol__ Stock Quote Price and Forecast - CNN

Humana (HUM) Stock Stays Near Fair Value As Earnings And Growth Pull Apart - Yahoo Finance

HUM Maintained by TD Cowen -- Price Target Raised to $350 - GuruFocus

Humana (NYSE:HUM) Price Target Raised to $415.00 - MarketBeat

Humana (HUM) Stock Looks Fully Priced On Illinois Medicaid Win - Sahm

Humana pops as Wells Fargo upgrades on moderating cost trends (HUM:NYSE) - Seeking Alpha

HUM — Frequently Asked Questions

What is the current share price of Humana Inc. (HUM)?

What is the market capitalisation of HUM?

What is the P/E ratio of HUM?

Does HUM pay a dividend?

What is the return on equity (ROE) of HUM?

Is HUM a good stock to buy?

Explore More